2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35038574/

Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients (2021)
https://pubmed.ncbi.nlm.nih.gov/34876490/

New-Onset Inflammatory Bowel Diseases Among IL-17 inhibitors-Treated Patients: Results From The Case-Control MISSIL Study (2021)
https://pubmed.ncbi.nlm.nih.gov/34730790/

Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials (2021)
https://pubmed.ncbi.nlm.nih.gov/34271991/

Sociodemographic determinants in the evolution of pain in inflammatory rheumatic diseases: results from ESPOIR and DESIR cohorts (2021)
https://pubmed.ncbi.nlm.nih.gov/34270700/

Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI) (2021)
https://pubmed.ncbi.nlm.nih.gov/34074455/

Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison (2021)
https://pubmed.ncbi.nlm.nih.gov/33232465/

Dactylitis in early spondyloarthritis. Data from the prospective French national cohort DESIR (2020)
https://pubmed.ncbi.nlm.nih.gov/31958574/

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/32349791/